Cheil Bio Co., Limited. operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cheil Bio Co., Limited. with three other
companies in this sector in South Korea:
Green Cross Cell Corp
sales of 29.61 billion Korean Won [US$25.58 million]
of which 100%
was Biotechnology (BT) Segment),
Eagle Veterinary Technology Co., Ltd
(30.26 billion Korean Won [US$26.15 million]
Pharmicell Company Limited
(28.35 billion Korean Won [US$24.50 million]
of which 82%
Cheil Bio Co., Limited. reported sales of 27.81 billion Korean Won (US$24.03 million)
December of 2018.
decrease of 0.6%
versus 2017, when the company's sales were 27.99 billion Korean Won.